Cutera, Inc. (CUTR) Financial Statements (2024 and earlier)

Company Profile

Business Address 3240 BAYSHORE BOULEVARD
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments267,651317,314250,826278,176131,779164,164
Cash and cash equivalents166,828145,92445,88075,05057,732164,164
Short-term investments100,823171,390204,946203,12674,047 
Restricted cash and investments700700    
Receivables61,26752,70935,87632,14833,16931,449
Inventory, net of allowances, customer advances and progress billings71,81963,62855,93845,41051,68039,503
Inventory71,81963,62855,93845,41051,68039,503
Prepaid expense2,8372,972    
Deposits current assets14,11813,917    
Other current assets 7     
Other undisclosed current assets 65 23,67217,57920,15614,545
Total current assets:418,464451,240366,312373,313236,784249,661
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization1,5351,6061,7911,253403392
Operating lease, right-of-use asset12,05912,83113,03313,77114,33014,627
Intangible assets, net (including goodwill)1,3391,3391,3391,3391,3391,339
Goodwill1,3391,3391,3391,3391,3391,339
Restricted cash and investments   700700700700
Deferred income tax assets577590626698737778
Other noncurrent assets14,34314,62011,6689,8019,79210,169
Other undisclosed noncurrent assets51,48138,76232,68823,2172,6062,627
Total noncurrent assets:81,33469,74861,84550,77929,90730,632
TOTAL ASSETS:499,798520,988428,157424,092266,691280,293
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities93,82991,18884,96772,90461,69061,991
Accounts payable35,16933,73634,17625,36513,6467,891
Accrued liabilities58,66057,45250,79147,53948,04454,100
Deferred revenue12,24311,84110,57910,0989,7199,490
Debt480485786542520554
Other undisclosed current liabilities2,2422,3251,9262,1722,1081,865
Total current liabilities:108,794105,83998,25885,71674,03773,900
Noncurrent Liabilities
Long-term debt and lease obligation417,011416,459311,898312,224147,469147,726
Long-term debt, excluding current maturities417,011416,459300,256299,856134,462134,243
Liabilities, other than long-term debt13,00613,8712,5072,2782,0252,098
Deferred revenue1,6431,6571,8221,4291,3451,335
Other liabilities711862685849680763
Operating lease, liability10,65211,35211,64212,36813,00713,483
Total noncurrent liabilities:430,017430,330314,405314,502149,494149,824
Total liabilities:538,811536,169412,663400,218223,531223,724
Equity
Equity, attributable to parent(39,013)(15,181)15,49423,87443,16056,569
Common stock202020201818
Additional paid in capital126,504125,406148,535144,628116,468114,724
Accumulated other comprehensive income (loss)(8)(94)(336)(183)(11) 
Accumulated deficit(165,529)(140,513)(132,725)(120,591)(73,315)(58,173)
Total equity:(39,013)(15,181)15,49423,87443,16056,569
TOTAL LIABILITIES AND EQUITY:499,798520,988428,157424,092266,691280,293

Income Statement (P&L) ($ in thousands)

6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
Revenues54,99367,35362,80864,22458,01465,629
Cost of revenue
(Cost of Goods and Services Sold)
(30,066)(28,604)(28,560)(29,180)(26,226)(27,448)
Gross profit:24,92738,74934,24835,04431,78838,181
Operating expenses(48,496)(44,285)(43,681)(45,108)(44,945)(40,210)
Operating loss:(23,569)(5,536)(9,433)(10,064)(13,157)(2,029)
Nonoperating expense(1,175)(1,488)(1,874)(37,398)(1,752)(1,425)
Other nonoperating income (expense)(163)(1,658)265(1,528)(755)(430)
Interest and debt expense(20)(22)(17)(16)(21)(19)
Loss from continuing operations before equity method investments, income taxes:(24,764)(7,046)(11,324)(47,478)(14,930)(3,473)
Other undisclosed income from continuing operations before income taxes202217162119
Loss from continuing operations before income taxes:(24,744)(7,024)(11,307)(47,462)(14,909)(3,454)
Income tax expense (benefit)(272)(764)(827)186(233)(481)
Loss from continuing operations:(25,016)(7,788)(12,134)(47,276)(15,142)(3,935)
Loss before gain (loss) on sale of properties:(12,134)(47,276)(15,142)(3,935)
Other undisclosed net income1,447     
Net loss:(23,569)(7,788)(12,134)(47,276)(15,142)(3,935)
Other undisclosed net loss attributable to parent(1,447)     
Net loss available to common stockholders, diluted:(25,016)(7,788)(12,134)(47,276)(15,142)(3,935)

Comprehensive Income ($ in thousands)

6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
Net loss:(23,569)(7,788)(12,134)(47,276)(15,142)(3,935)
Other undisclosed comprehensive loss  (94)    
Comprehensive loss:(23,569)(7,882)(12,134)(47,276)(15,142)(3,935)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,361)336(153)(172)(11) 
Comprehensive loss, net of tax, attributable to parent:(24,930)(7,546)(12,287)(47,448)(15,153)(3,935)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: